Goldman Sachs’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Buy
555,913
+144,259
+35% +$645K ﹤0.01% 4395
2025
Q4
$1.55M Buy
411,654
+392,389
+2,037% +$763K ﹤0.01% 4804
2025
Q3
$31K Sell
19,265
-446,241
-96% -$795K ﹤0.01% 6216
2025
Q2
$1.02M Buy
+465,506
New +$714K ﹤0.01% 4687
2025
Q1
Sell
-15,683
Closed -$16.3K 6373
2024
Q4
$16.3K Buy
+15,683
New +$17.9K ﹤0.01% 5917
2018
Q1
Sell
-74
Closed -$29K 6354
2017
Q4
$29K Sell
74
-3
-4% -$1.45K ﹤0.01% 6057
2017
Q3
$41K Sell
77
-11
-13% -$7.26K ﹤0.01% 6299
2017
Q2
$76K Sell
88
-55
-38% -$47.8K ﹤0.01% 6228
2017
Q1
$131K Buy
143
+137
+2,283% +$227K ﹤0.01% 5949
2016
Q4
$18K Buy
+6
New +$34.9K ﹤0.01% 6671

Other funds holding SLS